ArticleCancer research2009

PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancer.

Robert J Crowder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.